D
Exact Sciences Corporation EXAS
$56.72 $0.530.94% NASDAQ
Recommendation
Prev Close
$53.57
Volume
1,625,107
Avg Vol (90D)
3,057,340
Market Cap
$10.14B
Dividend & Yield
--
52-Week Range
$38.81 - $72.83
P/E (TTM)
--
EPS (TTM)
-$5.43
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Exact Sciences (EXAS, $56.72) RSI Indicator left the overbought zone on October 03, 2025
10/4/2025 - Tickeron - Stocks
Will Analyst Upgrades and Earnings Revisions Shift Exact Sciences' (EXAS) Investment Narrative?
10/3/2025 - Simply Wall St
Exact Sciences (EXAS): Evaluating Upside Potential as Analyst Optimism and New Catalysts Drive Attention
10/3/2025 - Simply Wall St
Exact Sciences (EXAS, $56.19) RSI Indicator left the overbought zone on October 02, 2025
10/3/2025 - Tickeron - Technical Analysis
Top Research Reports for Boston Scientific, Union Pacific & Realty Income
10/2/2025 - Zacks Investment Research
What Analysts Are Saying About Exact Sciences Stock
10/2/2025 - Benzinga
Exact Sciences (EXAS, $56.43) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
Exact Sciences (EXAS, $56.43) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 1, 2025
10/2/2025 - Tickeron - Stocks
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
10/2/2025 - Zacks Investment Research
Exact Sciences price target raised by $10 at Barclays, here's why
10/2/2025 - The Fly
Exact Sciences (EXAS) Gains Attention with Compelling Valuation and Potential Growth
10/1/2025 - GuruFocus
Exact Sciences added to Q4 2025 Tactical Ideas List at Wells Fargo
10/1/2025 - The Fly
Ballentine Partners LLC Buys Shares of 4,838 Exact Sciences Corporation $EXAS
9/30/2025 - MarketBeat
Exact Sciences Corporation $EXAS Shares Sold by Park Avenue Securities LLC
9/27/2025 - MarketBeat
Bank Pictet & Cie Europe AG Purchases 34,914 Shares of Exact Sciences Corporation $EXAS
9/26/2025 - MarketBeat
Exact Sciences' Clear Expansion Path: Why Choose To Buy
9/25/2025 - SeekingAlpha
Exact Sciences' Clear Expansion Path: Why Choose To Buy
9/25/2025 - Seeking Alpha - Long Ideas
A Fresh Look at Exact Sciences (EXAS): Is the Current Valuation Attractive for Investors?
9/24/2025 - Simply Wall St
Exact Sciences (EXAS, $52.41) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 23, 2025
9/24/2025 - Tickeron - Technical Analysis
Exact Sciences management to meet with Craig-Hallum
9/23/2025 - The Fly
Is Cancerguard's Launch With Quest Diagnostics Altering the Investment Case for Exact Sciences (EXAS)?
9/22/2025 - Simply Wall St
Guggenheim Reaffirms Their Hold Rating on GRAIL Inc (GRAL)
9/22/2025 - TipRanks Financial Blog
exact sciences scares spooky season cologuard campaign starring matthew lillard
9/22/2025 - FiercePharma
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard Test
9/22/2025 - Business Wire
Pallas Capital Advisors LLC Purchases 4,925 Shares of Exact Sciences Corporation $EXAS
9/20/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$2.94B
EBITDA (TTM)
$78.28M
EBIT (TTM)
-$138.98M
Net Income (TTM)
-$1.01B
Balance Sheet
Total Assets (Q)
$5.80B
Total Debt (Q)
$2.54B
Total Liabilities (Q)
$3.33B
Book Value Per Share (Q)
$13.05
Cash Flow
Cash from Operations (TTM)
$305.61M
Cash from Investing (TTM)
$66.87M
Cash from Financing (TTM)
-$250.41M
Net Change in Cash (TTM)
$121.08M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.64
7-Day Total Return
5.84%
30-Day Total Return
24.39%
60-Day Total Return
6.30%
90-Day Total Return
-1.89%
Year to Date Total Return
-0.36%
1-Year Total Return
-14.01%
2-Year Total Return
-15.92%
3-Year Total Return
77.42%
5-Year Total Return
-43.11%
52-week Low
Aug 07, 2025 - $38.81
52-week High
Nov 05, 2024 - $72.83
Valuation
Market Cap
$10.14B - Large Cap
Enterprise Value
$11.82B
Price/Sales (TTM)
3.44
Price/Book (Q)
4.10
Dividends and Shares
Shares Outstanding
188.90
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.exactsciences.com
Phone Number
608 284 5700
Address
5505 Endeavor Lane
Madison, WI 53719
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to... more
NASDAQ 10/03/2025 4:00PM Eastern Quotes delayed